OpenAlex
PricingAboutJobs
Log inGet started
Work

FDA Approves First KRAS Inhibitor: Sotorasib

HTML

Year: 2021
Type: article
Source: Cancer Discovery
DOI: 10.1158/2159-8290.cd-nb2021-0362
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: sotorasib, KRAS G12C mutation, KRAS inhibitors, non-small cell lung cancer, FDA drug approval, targeted therapy, progression-free survival, platinum-based chemotherapy, PD-1/PD-L1 inhibitors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4206804220
FWCI: 6.223
Cites:
Cited by: 62
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security